The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multicenter randomized phase II study of NPC-1C (N) in combination with gemcitabine (G) and nab-paclitaxel (A) versus G and A alone in patients with metastatic or locally advanced pancreatic cancer (PC) previously treated with folfirinox (F).
 
Austin G. Duffy
No Relationships to Disclose
 
Muhammad Shaalan Beg
No Relationships to Disclose
 
Tim F. Greten
No Relationships to Disclose
 
Melony A. Beatson
Employment - Precision BioLogic
 
Sharon Mavroukakis
Consulting or Advisory Role - Precision BioLogic
 
Sandip Pravin Patel
No Relationships to Disclose
 
Michael A. Morse
No Relationships to Disclose
 
Philip M. Arlen
Employment - Precision BioLogic
Leadership - Precision BioLogic
Stock and Other Ownership Interests - Precision BioLogic
Travel, Accommodations, Expenses - Precision BioLogic